Boehringer Ingelheim Establishes Steering Committee on Obesity and Liver Disease

Boehringer Ingelheim established a steering committee focused on more connected care for obesity and related liver diseases. The source cites estimates that 75% of people with obesity have MASLD and 34% have its more—an incomplete statement.